Vasoconstrictor-Anti-acne Kit for Reducing Lesion Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-acne treatments face challenges due to the rapid diffusion of topical agents away from acne lesions, leading to reduced efficacy as they diffuse out quickly from the treatment area.
Innovation Solution
The use of a vasoconstricting agent is applied prior to an anti-acne agent to reduce outflow, maintaining a higher concentration of the anti-acne agent at the lesion site, thereby enhancing treatment efficacy and reducing redness and swelling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a topical anti-acne agent is applied to the skin, then the agent can treat acne lesions, but the agent diffuses rapidly away from the lesion site reducing its efficacy
Solution Approach 1:
A vasoconstricting agent is used as an intermediary substance applied before the anti-acne agent. This vasoconstrictor constricts blood vessels in the skin, creating a temporary barrier that reduces the diffusion and outflow of the anti-acne agent from the treatment area, thereby maintaining higher local concentrations of the active ingredient at the lesion site
Solution Approach 2:
The vasoconstricting agent is applied in advance before the anti-acne agent to prepare the skin environment. By pre-constricting the blood vessels, the subsequent anti-acne agent is retained longer at the treatment site, enhancing its effectiveness without requiring higher doses
2Quantity of substance
If a vasoconstricting agent is applied prior to anti-acne agent, then the outflow of anti-acne agent is reduced and local concentration is increased, but the treatment protocol becomes more complex
Solution Approach 1:
The vasoconstricting agent is applied in advance before the anti-acne agent to prepare the skin environment. By pre-constricting the blood vessels, the subsequent anti-acne agent is retained longer at the treatment site, enhancing its effectiveness without requiring higher doses
Solution Approach 2:
The patent combines two separate functional agents (vasoconstrictor and anti-acne agent) into a coordinated treatment sequence. While this increases protocol steps, the vasoconstrictor serves dual purposes: constricting vessels to retain the anti-acne agent and simultaneously reducing redness and swelling of the lesion
3Duration of action of moving object
If topical anti-acne agents are used, then acne lesions can be treated, but the agents diffuse quickly reducing their dwell time in the dermis
Solution Approach 1:
A vasoconstricting agent is used as an intermediary substance applied before the anti-acne agent. This vasoconstrictor constricts blood vessels in the skin, creating a temporary barrier that reduces the diffusion and outflow of the anti-acne agent from the treatment area, thereby maintaining higher local concentrations of the active ingredient at the lesion site
Solution Approach 2:
The vasoconstricting agent changes the physiological parameters of the skin by constricting blood vessels, which reduces blood flow and creates a more favorable environment for retaining the anti-acne agent. This parameter change (reduced blood flow) directly extends the dwell time of the anti-acne agent in the dermis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases the local dermal dwell time of anti-acne agents, promoting healing and preventing further acne outbreaks while effectively reducing the visibility of acne lesions.
Implementation Method 1
The use of a vasoconstricting agent is applied prior to an anti-acne agent to reduce outflow
Implementation Method 2
the rapid diffusion of topical agents away from acne lesions
Data Source
AI summary
This invention provides anti-acne kits that are useful for treating acne, especially severe cases of acne. The anti-acne kits include a vasoconstrictor and an anti-acne agent, and optionally one or more of a a skin lightening therapeutic, a sealing layer, a skin cleanser, an astringent, a skin penetration enhancer, a sunscreen, and nutritional supplements that promote healing of acne lesions. This invention also provides methods for treating acne using a vasoconstrictor in conjunction with an anti-acne agent.